These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15548484)

  • 1. Apolipoprotein E genotypes do not influence the age of onset in Huntington's disease.
    Saft C; Andrich JE; Brune N; Gencik M; Kraus PH; Przuntek H; Epplen JT
    J Neurol Neurosurg Psychiatry; 2004 Dec; 75(12):1692-6. PubMed ID: 15548484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age of onset in Huntington disease: sex specific influence of apolipoprotein E genotype and normal CAG repeat length.
    Kehoe P; Krawczak M; Harper PS; Owen MJ; Jones AL
    J Med Genet; 1999 Feb; 36(2):108-11. PubMed ID: 10051007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Apolipoprotein E Genotypes on Huntington's Disease Phenotypes in a Han Chinese Population.
    Li XY; Zhang YB; Xu M; Cheng HR; Dong Y; Ni W; Li HL; Wu ZY
    Neurosci Bull; 2019 Aug; 35(4):756-762. PubMed ID: 30887245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E and presenilin-1 genotypes in Huntington's disease.
    Panas M; Avramopoulos D; Karadima G; Petersen MB; Vassilopoulos D
    J Neurol; 1999 Jul; 246(7):574-7. PubMed ID: 10463359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of potential interactive genetic factors in Huntington's disease.
    Panegyres PK; Beilby J; Bulsara M; Toufexis K; Wong C
    Eur Neurol; 2006; 55(4):189-92. PubMed ID: 16772714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The number of CAG repeats within the normal allele does not influence the age of onset in Huntington's disease.
    Klempíř J; Zidovská J; Stochl J; Ing VK; Uhrová T; Roth J
    Mov Disord; 2011 Jan; 26(1):125-9. PubMed ID: 21322024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E polymorphism in Pick's disease and in Huntington's disease.
    Kálmán J; Juhász A; Majtényi K; Rimanóczy A; Jakab K; Gárdián G; Raskó I; Janka Z
    Neurobiol Aging; 2000; 21(4):555-8. PubMed ID: 10924769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutathione S-Transferase Omega 1 variation does not influence age at onset of Huntington's disease.
    Arning L; Jagiello P; Wieczorek S; Saft C; Andrich J; Epplen JT
    BMC Med Genet; 2004 Mar; 5():7. PubMed ID: 15040808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haplotype analysis of the CAG and CCG repeats in 21 Brazilian families with Huntington's disease.
    Agostinho Lde A; Rocha CF; Medina-Acosta E; Barboza HN; da Silva AF; Pereira SP; da Silva Idos S; Paradela ER; Figueiredo AL; Nogueira Ede M; Alvarenga RM; Hernan Cabello P; dos Santos SR; Paiva CL
    J Hum Genet; 2012 Dec; 57(12):796-803. PubMed ID: 23051704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the correlates of intermediate CAG repeats in Huntington disease.
    Ha AD; Jankovic J
    Postgrad Med; 2011 Sep; 123(5):116-21. PubMed ID: 21904093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein epsilon4 advances appearance of psychosis in patients with Parkinson's disease.
    Feldman B; Chapman J; Korczyn AD
    Acta Neurol Scand; 2006 Jan; 113(1):14-7. PubMed ID: 16367893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 mice.
    Morton AJ; Glynn D; Leavens W; Zheng Z; Faull RL; Skepper JN; Wight JM
    Neurobiol Dis; 2009 Mar; 33(3):331-41. PubMed ID: 19130884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methyltetrahydrofolate reductase polymorphism influences onset of Huntington's disease.
    Brune N; Andrich J; Gencik M; Saft C; Müller T; Valentin S; Przuntek H; Epplen JT
    J Neural Transm Suppl; 2004; (68):105-10. PubMed ID: 15354395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low plasma total cholesterol in patients with Huntington's disease and first-degree relatives.
    Markianos M; Panas M; Kalfakis N; Vassilopoulos D
    Mol Genet Metab; 2008 Mar; 93(3):341-6. PubMed ID: 18006350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism of HD and UCHL-1 genes in Huntington's disease.
    Xu EH; Tang Y; Li D; Jia JP
    J Clin Neurosci; 2009 Nov; 16(11):1473-7. PubMed ID: 19683447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Importance of the number of trinucleotide repeat expansions in the clinical manifestations of Huntington's chorea].
    Vojvodić N; Culjković B; Romac S; Stojković O; Sternić N; Sokić D; Kostić VS
    Srp Arh Celok Lek; 1998; 126(3-4):77-82. PubMed ID: 9863360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replication of twelve association studies for Huntington's disease residual age of onset in large Venezuelan kindreds.
    Andresen JM; Gayán J; Cherny SS; Brocklebank D; Alkorta-Aranburu G; Addis EA; ; Cardon LR; Housman DE; Wexler NS
    J Med Genet; 2007 Jan; 44(1):44-50. PubMed ID: 17018562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical picture of patients with Huntington's disease in relation to the number of trinucleotide CAG repeats in IT-15 gene].
    Zielonka D; de Mezer M; Niezgoda A; Reperowicz K; Krzyzosiak W; Kozubski W
    Neurol Neurochir Pol; 2002; 36(5):903-9. PubMed ID: 12523115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of a very large trinucleotide repeat in a patient with juvenile Huntington's disease.
    Nance MA; Mathias-Hagen V; Breningstall G; Wick MJ; McGlennen RC
    Neurology; 1999 Jan; 52(2):392-4. PubMed ID: 9932964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.